Vavricka John sold AVIR
January 31, 2026 · Form 4 insider transaction
Vavricka John sold 33,333 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
33,333
Price
$0.00
Total value
N/A
InsiderVavricka John
RoleOfficer
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026.